Target intelligence / Profile preview

Actinin alpha 4 pseudogene 1 (ACTN4P1)

Target
ACTN4P1
Molecular classification
Other (Pseudogene)
01

Overview

Actinin alpha 4 pseudogene 1 (ACTN4P1) is classified as a pseudogene, a non-protein-coding genomic sequence related to the ACTN4 gene. It is present on chromosome 4 and has one transcript but does not encode an actin-binding protein or participate in cellular functions attributed to the functional ACTN4 protein. Pseudogenes like ACTN4P1 may be transcribed and differentially expressed in various conditions, including aging and progeria[6][7], but do not themselves act as therapeutic targets, receptors, or enzymes. ACTN4P1 is often confused with ACTN4 (alpha-actinin-4), which is a well-studied actin-binding protein involved in cellular migration, cytoskeleton organization, and certain diseases like kidney disorders and cancer[2][3][5]. ACTN4P1, in contrast, does not produce the alpha-actinin-4 protein and has no established drug interactions or biological activity. While ACTN4P1 may be referenced in omics studies as a differentially expressed pseudogene, especially in aging and progeria research[7], current data do not support its use as a therapeutic target, biomarker, or mechanistic entity in disease. Actinin alpha 4 pseudogene 1 (ACTN4P1) is a pseudogene, not a receptor, enzyme, transporter, or other functional protein. It should not be designated as a drug target or biological entity for therapeutic interventions[4][6][7][8].

Other names
Actinin alpha 4 pseudogene 1ACTN4P1

Beyond the preview

Go deeper on Actinin alpha 4 pseudogene 1 (ACTN4P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actinin alpha 4 pseudogene 1 (ACTN4P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call